Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

NCT00165412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2019-05-02

No results posted yet for this study

Summary

The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.

Conditions

Interventions

PROCEDURE

breast MRI

Repeated once a year for three years

PROCEDURE

Mammogram

Repeated once a year for three years

Sponsors & Collaborators

Principal Investigators

  • Andrea K. Ng, MD · Dana-Farber Cancer Institute

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00165412 on ClinicalTrials.gov